Abstract:Dear Editor, Breath analysis is a promising diagnostic approach for various conditions [1, 2]. It is based on the identification of volatile organic compounds (VOCs) emitted in the breath, which creates a unique volatolomic signature [3]. Owing to their characteristics, VOCs can be measured non-intrusively from the breath or other body sources [3, 4]. Several studies have shown the diagnostic potential for a variety of conditions based on VOC analysis [5-9]. Malignant diseases, where early detection is crucial, are the main focus of VOC analysis, with lung cancer (LC) and gastric cancer (GC) being the most studied. LC and GC together were responsible for approximately 2.5 million deaths globally in 2018 [10]. The aim of VOC analysis of the breath using sensors is to identify a “VOC-print” comprising the total abundances and ratios of the compounds in the breath, giving an overall unique chemical pattern [11]. This technology can help to address specific challenges concerning LC screening and GC mortality [12,13]. To facilitate real-world applications, different ethnicand culture-based populations should be sampled. Here, we carried out a VOC-based clinical trial for GC and LC detection in China to classify these two major malignancies with different genetic and cultural backgrounds, using our developed sensors [1] with newly-developed sensor-printing and sampling methods. A total of 545 breath samples (one/two samples per subject) were collected from 426 adult participants between January 2018 and July 2019 at the Jiangyin Hospital Affiliated to the Southeast University Medical College in China. The study population consisted of three groups: LC patients (n = 158), GC patients (n = 115), and healthy volunteers (n = 153), as detailed in Table 1. All participants gave their informed consent for inclusion before participating in the study. Exhaled alveolar breath was collected in a controlled manner. End-tidal expired air was directly trapped and preconcentrated in Tenax TA sorption tubes (Buchem BV,

Human Exhaled Breath Analysis Trends in Techniques and Its Potential Applications in Non-Invasive Clinical Diagnosis

The research on early detection of lung cancer with exhaled volatile organic compounds

A Study of the Volatile Organic Compounds Exhaled by Lung Cancer Cells in Vitro for Breath Diagnosis

Screening and Bioinformatics Analysis of Lung Cancer Exhale Breath Biomarkers

Spme-Gc Analysis of Alkanes and Aromatic Hydrocarbons in Human Breath to Screen Lung Cancer

Solid Phase Microextraction for Analysis of Alkanes and Aromatic Hydrocarbons in Human Breath

Current Status of Methods and Techniques for Breath Analysis

Exhaled Breath Analysis in Disease Detection

Methods for detection of volatile organic compounds in human exhaled breath

Breath Analysis: Potential for Clinical Diagnosis and Exposure Assessment.

GC-Based Techniques for Breath Analysis: Current Status, Challenges, and Prospects

Non-invasive Exhaled Breath Diagnostic and Monitoring Technologies

Gas-Sensing Technology for Human Breath Detection

Breath analysis for the screening and diagnosis of diseases

Direct Mass Spectrometry Analysis of Exhaled Human Breath in Real‐time

Exhaled Breath Analysis: from Laboratory Test to Wearable Sensing

Breath Analysis: Technical Developments and Challenges in the Monitoring of Human Exposure to Volatile Organic Compounds.

Direct mass spectrometry analysis of exhaled human breath in real-time.

Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis

Exhaled Breath Diagnostics of Lung and Gastric Cancers in China Using Nanosensors

Volatile organic compounds in cancer and exhaled breath detection technology